Arkolith/Insider Trading/ARQT/Form 4

Welgus Howard G.

DirectorArcutis Biotherapeutics, Inc. (ARQT) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$116K
Net Open-Market Flow
-$116K
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Sell(S)635$25.67$16K38K
Jun 15, 2026Option exercise(M)1K$7.51$8K40K
Jun 15, 2026Option exercise(M)2K$8.63$19K42K
Jun 15, 2026Sell(S)4K$24.41$100K38K
Jun 15, 2026Option exercise(M)822$6.52$5K39K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)822—$09K
Jun 15, 2026Option exercise(M)1K—$011K
Jun 15, 2026Option exercise(M)2K—$025K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-044079) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML